Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter &gt; 2 cm)—IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201
PloS one